Antinuclear Antibody (ANA)
The antinuclear antibody (ANA) test looks for antibodies that target the nucleus of your own cells. It is a broad screening test used when an autoimmune condition is being considered.
Because ANA is one of the first tests ordered when symptoms like joint pain, fatigue, rashes, or unexplained inflammation suggest the immune system may be reacting against the body's own tissues. It helps a clinician decide whether more specific autoimmune testing is worthwhile. On its own, ANA is a starting point rather than a diagnosis.
A positive ANA can be associated with autoimmune conditions such as lupus, Sjögren's, or scleroderma, and results are often reported with a titer (strength) and pattern that guide next steps. Importantly, a positive ANA is common in healthy people too, especially at low titers and with increasing age, so a positive result does not by itself mean you have an autoimmune disease.
A negative ANA is generally reassuring and makes several ANA-associated autoimmune conditions less likely, though it does not completely rule everything out. Your clinician interprets it alongside your symptoms and other tests.
A negative result is typical. Any positive or borderline result is best interpreted by your clinician together with your symptoms, titer, and pattern.
Sources
- ANA (Antinuclear Antibody) Test · MedlinePlus
- Antinuclear Antibodies (ANA) · American College of Rheumatology
Educational context only, not medical advice or a diagnosis. Reference ranges vary by lab, age and sex; always discuss your results with a clinician.